Companies: 10,795·Total market cap: $144.5T
Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc

JAZZNASDAQHealthcare● Active
$238.99
+$0.42(+0.18%)
Market Cap$15.0B
P/E Ratio
52W High$243.32
52W Low$105
Overview

Jazz Pharmaceuticals plc(JAZZ)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · JAZZ · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$4.27B$4.07B$3.83B$3.66B$3.09B
Cost of Revenue$0.50B$0.45B$0.44B$0.54B$0.44B
Gross Profit$3.76B$3.62B$3.40B$3.12B$2.65B
Gross Margin %(computed)88.21%89.05%88.64%85.23%85.76%
Operating Expenses
R&D Expenses$0.78B$0.88B$0.85B$0.59B$0.51B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$3.54B$2.91B$2.82B$3.18B$2.48B
Operating Income$0.22B$0.72B$0.58B($0.07B)$0.17B
Operating Margin %(computed)5.26%17.61%15.09%-1.79%5.50%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.20B$0.24B$0.29B$0.29B$0.28B
Income Before Tax($0.63B)$0.47B$0.29B($0.38B)($0.11B)
Income Tax Expense($0.27B)($0.09B)($0.12B)($0.16B)$0.22B
Net Income($0.36B)$0.56B$0.41B($0.22B)($0.33B)
Net Margin %(computed)-8.35%13.77%10.82%-6.12%-10.63%
Per Share & EBITDA
EPS (Basic)$-5.84$9.06$6.55$-3.58$-5.51
Wtd Avg Shares0.06B0.06B0.06B0.06B0.06B
EBITDA$0.11B$1.52B$1.45B$1.47B$1.03B
EBITDA Margin %(computed)2.54%37.40%37.80%40.13%33.21%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Jazz Pharmaceuticals plc

关于Jazz Pharmaceuticals plc(JAZZ)损益表

Jazz Pharmaceuticals plc(JAZZ)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,JAZZ实现营收$4.27B,毛利润$3.76B(毛利率88.21%),净利润($0.36B)(净利率-8.35%)。

常见问题

JAZZ · 4 问

Jazz Pharmaceuticals plc(JAZZ)2025财年营收为$4.27B,同比up4.9%。

JAZZ revenueJAZZ salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08